• Mashup Score: 1

    Home > Progress in Geriatric Oncology: Reviewing the ASCO Guideline Dr. Chadi Nabhan sits down with 3 experts from the Cancer and Aging Research Group who contributed to the American Society of Clinical Oncology guideline on the practical assessment and management of age-associated vulnerabilities in older patients receiving systemic cancer therapy: William Dale, MD, PhD, FASCO, of the City of Hope Comprehensive Cancer Center; Supriya Mohile, MD, MS, of the University of Rochester; and Heidi Klepin, MD,

    Tweet Tweets with this article
    • @chadinabhan sits down with 3 experts from the Cancer and Aging Research Group who contributed to the American Society of Clinical Oncology to discuss vulnerabilities in older patients receiving systemic cancer therapy. #cancertherapy #ASCO https://t.co/y5WqVEuU6g https://t.co/aKcfYFOqCP

  • Mashup Score: 1

    Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care

    Tweet Tweets with this article
    • Large randomized clinical trials could lead to unintentional bias because of an imbalance of assigned treatment discontinuations between experimental and control arms, according to Faris Tamimi, MD, at @pmcancercentre. Listen to the podcast here: https://t.co/OpGw1SC2s8 #ASCO https://t.co/V1mXMyS7SD

  • Mashup Score: 1

    This meeting will showcase abstracts from highly-rated ASCO 2023 presentations, breaking down the key takeaways to directly impact patient care. Attendees will engage in real-time with the experts presenting and colleagues local to Pennsylvania.

    Tweet Tweets with this article
    • Total Health- #ASCO Direct Philadelphia Conf. Sonesta Philadelphia Rittenhouse Square Sept. 23-24, 2023. Earn 7.50 CME/CE Credits Register Free: https://t.co/AyjVq0TKoh #Meded #ASCO https://t.co/SJBEIIDVUA

  • Mashup Score: 0

    In this review, we discuss the use of measurable residual disease (MRD) in AML, ALL, and chronic myeloid leukemia (CML). Our aims were to review the different methodologies for MRD assessment; describe the clinical relevance and medical decision making on the basis of MRD; compare and contrast the usage of MRD across AML, ALL, and CML; and discuss what patients need to know about MRD as it relates to their disease status and treatment. Finally, we discuss ongoing challenges and future directions with the goal of optimizing MRD usage in leukemia management.

    Tweet Tweets with this article
    • Learn more about the use of #MRD to optimize management of #AML, #ALL, and #CML by checking out our new #ASCOEdBook review on this emerging topic! https://t.co/DzJZYIgY9H #ASCO #LEUSM @DrSimoneDekker #ASCO23 https://t.co/4pxMSTyzLc

  • Mashup Score: 8

    CarouselUncategorized New 2023 ASCO Geriatric Oncology Updated Guidelines: Practical Geriatric Assessment and Other Resources July 10, 2023July 17, 2023 Rolando Mantilla Welcome to CARG! The mission of the Cancer and Aging Research Group is to join geriatric oncology…

    Tweet Tweets with this article
    • The new #GeriOnc Guidelines from #ASCO are out!! Very proud to lead the esteemed group of researchers, clinicians, patient partners, nurses, and so many others to make this a reality. More to come! Follow https://t.co/l1x8DGCrDT for more updates. https://t.co/5GXnUbsMbn